Page 4 - Louism Weiner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Louism weiner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Louism Weiner Today - Breaking & Trending Today

Jounce Therapeutics (NASDAQ:JNCE) Now Covered by StockNews.com

StockNews.com began coverage on shares of Jounce Therapeutics (NASDAQ:JNCE – Get Rating) in a research note published on Saturday. The brokerage issued a hold rating on the stock. JNCE has been the subject of several other reports. Sumitomo Mitsui Financial Group reissued a neutral rating on shares of Jounce Therapeutics in a research report on […] ....

United Kingdom , Thomasf Gajewski , Jamesp Allison , Piper Sandler , Padmanee Sharma , Kevinc Tang , Raymond James , Louism Weiner , Robert Schreiber , Jounce Therapeutics Inc , Jounce Therapeutics Company Profile , Millennium Management , Securities Exchange Commission , Capital Management , Voya Investment Management , Sumitomo Mitsui Financial Group , Squarepoint Ops , Investment Advisers , Jounce Therapeutics , Get Rating , Mitsui Financial Group , Exchange Commission , Director Richard , Investment Management , Jounce Therapeutics Daily , Nasdaq Jnce ,

Jounce Therapeutics, Inc. (NASDAQ:JNCE) Receives Average Rating of "Hold" from Analysts

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock. ....

United Kingdom , United States , Thomasf Gajewski , Kevinc Tang , Raymond James , Jamesp Allison , Piper Sandler , Robert Schreiber , Louism Weiner , Padmanee Sharma , Securities Exchange Commission , Jounce Therapeutics Company Profile , Jounce Therapeutics Inc , America Corp , Sumitomo Mitsui Financial Group , Capital Management , Millennium Management , Jounce Therapeutics , Get Rating , Marketbeat Ratings , Mitsui Financial Group , Exchange Commission , Director Richard , Jounce Therapeutics Daily ,

Jounce Therapeutics, Inc. (NASDAQ:JNCE) Sees Large Decrease in Short Interest

Jounce Therapeutics, Inc. (NASDAQ:JNCE – Get Rating) saw a significant drop in short interest in March. As of March 31st, there was short interest totalling 2,280,000 shares, a drop of 28.3% from the March 15th total of 3,180,000 shares. Approximately 5.2% of the shares of the stock are short sold. Based on an average daily […] ....

United States , United Kingdom , Piper Sandler , Padmanee Sharma , Robert Schreiber , Thomasf Gajewski , Louism Weiner , Raymond James , Kevinc Tang , Jamesp Allison , Jounce Therapeutics Company Profile , Principal Financial Group Inc , Securities Exchange Commission , Jounce Therapeutics Inc , American International Group Inc , Silverarc Capital Management , Cubist Systematic Strategies , Sumitomo Mitsui Financial Group , Jounce Therapeutics , Get Rating , Exchange Commission , Director Richard , Capital Management , International Group , Financial Group , Systematic Strategies ,

Kingstone Companies (NASDAQ:KINS) Stock Crosses Below 200 Day Moving Average of $1.59

Should You Buy or Sell Jounce Therapeutics Stock? Get The Latest JNCE Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. ....

United Kingdom , Robert Schreiber , Thomasf Gajewski , Louism Weiner , Piper Sandler , Padmanee Sharma , Jamesp Allison , Kevinc Tang , Raymond James , Sumitomo Mitsui Financial Group , Balyasny Asset Management , Investment Advisers , Jounce Therapeutics Inc , Squarepoint Ops , Jounce Therapeutics Company Profile , Susquehanna International Group , Jounce Therapeutics , Get Rating , Mitsui Financial Group , Director Richard , Asset Management , International Group , Jounce Therapeutics Daily ,

StockNews.com Initiates Coverage on Jounce Therapeutics (NASDAQ:JNCE)

StockNews.com began coverage on shares of Jounce Therapeutics (NASDAQ:JNCE – Get Rating) in a research report sent to investors on Friday. The firm issued a hold rating on the stock. A number of other brokerages also recently issued reports on JNCE. Piper Sandler downgraded Jounce Therapeutics from an overweight rating to a neutral rating in […] ....

United Kingdom , Padmanee Sharma , Robert Schreiber , Jamesp Allison , Piper Sandler , Thomasf Gajewski , Raymond James , Kevinc Tang , Louism Weiner , Jounce Therapeutics Inc , Health Sciences , Wealth Group , Investment Advisers , Capital Management , Balyasny Asset Management , Sumitomo Mitsui Financial Group , Jounce Therapeutics , Get Rating , Mitsui Financial Group , Director Richard , Asset Management , Jounce Therapeutics Daily , Nasdaq Jnce , Initiated Coverage , Stocknews Com ,